Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:CSCI - Post by User

Comment by Tropicalsunon Sep 25, 2024 1:30pm
107 Views
Post# 36240576

RE:The Era of Gilles is over

RE:The Era of Gilles is over
BoazKhorn wrote: Gilles continues to exceed even the most pessimistic forecasts and on that note he is bowing out. Now that there is really nothing in the pipeline to lie about no more new ideas to spin to the suckers he is going.. Everything is years out and Gilles just doesnt have that kind of time so he is passing the guttering sputtering torch that is Ceapro, with no prosepects and massive cash burn to a new generation. Ceapro equivalent share is now around 5 cents. What a run this man has had somebody needs to write a book. Maybe the Proph his evil little sidekick could knock out a few pages as a tribute the the myth the man the legend that stole so much for so long and walked away rich.  Anyhow this dog is done stick a fork in it. There are no bids and 1000 offered at 4.3 what a mess. 


I completely understand the frustration and dissapointment of every shareholder today. Gilles has to go, the BOD are finally waking up and have made this decision. I could be wrong, but I highly doubt this would be gagnon's personal choice.

As bad as things may seem today, there is still a company that exsists and with the right person to lead as the new CEO, there are exciting opportunities in the pipeline. The worst part unfortuneatly is it will now take more time. Many of you have been shareholders for years and are likely under water with this investment. You all have choices to make.

To conclude this post, it is my view that the current I.R. firm must be terminated as well, they have done nothing to earn the money paid to them. Also the self proclaimed Phrophet must be muzzled as well, the connection to Gilles and Ceapro is too obvious.

The above post is only my personal opinion, take from it what you will.



<< Previous
Bullboard Posts
Next >>